Articles by Christopher J. Worrell - Pharmaceutical Executive

ADVERTISEMENT

Articles by Christopher J. Worrell

Christopher J. Worrell


Whose Afraid of Authorized Generics
October 1, 2005

No brand manufacturers plan to market generic versions of their own product, at least not until the patent expires. And why would they? As long as the branded version enjoys patent protection, marketing a cut-rate product would eat away profit margin during the years when a drug makes the most money.

ADVERTISEMENT

Click here